| To talk to an attorney call 800-200-6303 |
||
| Stevens-Johnson Syndrome (SJS) |
Before you discontinue use of this or ANY medication you need to consult your doctor or a medical professional, as dangerous side effects are possible with sudden discontinuation of use.
SJS is a potentially deadly skin disease that usually results from a drug reaction. SJS has been associated with over-the-counter pain relievers including Advil, Motrin, Tylenol, Dilantin, Phenytoin and Children's Motrin. See www.stevensjohnsonsyndromelawsuits.com for more detailed information regarding SJS.

What you should know about SJS:
SJS makes the outer layer of your skin die and fall off. Painful blisters and/or sores grow on your body that look like targets. These sores will usually grow in your mouth first, and may make it hard to swallow and breathe. Sores and blisters then spread to your skin, and may be very painful and feel like burning. You may have blisters and sores in your eyes and genitals. You may also have sores in your stomach, lungs, and colon (bowel). Layers of the skin often peel away in sheets. When your skin dies and falls off, it will be dark red and look badly burned. Stevens Johnson Syndrome can affect any age group. However, it occurs most commonly in older people who tend to use more of the drugs associated with the disease and are therefore collectively more at risk from the disease. |
Causes of SJS: SJS causes are broken into four different categories:
Some experts agree that a reaction to Dilantin can cause the onset of SJS. While Dilantin has been recalled numerous times since its introduction, it is still prescribed today. Underlying viral infections that have been associated with Stevens Johnson Syndrome include herpes simplex, AIDS, coxackie viral infections, influenza, hepatitis, mumps, mycoplasmal infections and others. |
Recognition of the early symptoms of SJS and prompt medical attention are the most invaluable tools in minimizing the possible long-term effects SJS may have on its victims.
SJS News/Resources http://emedicine.medscape.com/article/756523-overview
Other drug manufacturer cases |